Marvell Technology AFFECTED by Weaker Demand and 4 Stock Analyses to Notice Now

Procera Networks, Inc. (AMEX:PKT) is expected by Stifel Nicolausto reiterate its guidance for more than 30 percent revenue growth in 2012, and it maintains a $27 target and Buy rating on the shares.

Uroplasty Inc. (NASDAQ:UPI) target was increased by Roth Capital due to a sizable year-over-year is US. Urgent PC sales for the company. The firm keeps its  Buy rating on the stock.

Don’t Miss: Apple and Samsung Draw Swords TODAY.

Marvell Technology Group Ltd. (NASDAQ:MRVL) estimates were reduced by CLSA because of weaker HDD demand and more competitive pressures in the TD smartphone market. Shares have an Outperform rating.

Heartware International Inc. (NASDAQ:HTWR) is still favored by Canaccord,  but would suggest owning Hold rated Thoratec (NASDAQ:THOR) to balance out risk within the group. The firm believes both are attractive M&A targets, and it predicts strong clinical outcomes from both HM-II and HVAD to increase LVAD market expansion.

Domtar Corporation (NYSE:UFS) target was lowered by BMO Capital following the company’s report of lower than expected Q2 EPS from operations. The firm believes that copy paper price will fall this year, and it predicts that the pulp price war will keep going. The firm keeps an Outperform rating on the stock.

Don’t Miss: The Week Ahead: BIG Earnings On Deck, Fed Mulls EASING, July Unemployment.

Want news like this in real-time so you can get an edge? Click here for Wall St. Cheat Sheet Pro.